Use of Real‐World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of Real‐World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design

Published:2021-11-28 Issue:1 Volume:111 Page:77-89
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Dagenais Simon¹,Russo Leo²,Madsen Ann³,Webster Jen¹,Becnel Lauren¹

Affiliation:

1. Real World Evidence Pfizer Inc New York New York USA

2. Global Medical Epidemiology, Worldwide Medical and Safety Pfizer Inc Collegeville Pennsylvania USA

3. Global Medical Epidemiology, Worldwide Medical and Safety Pfizer Inc New York New York USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2480

Reference97 articles.

1. Opportunities and challenges in using real-world data for health care

2. Nonrandomized Real‐World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project

3. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐World Evidence Application in Translational Medicine: Making Use of Prescription Claims to Inform Drug–Drug Interactions of a New Psoriasis Treatment;The Journal of Clinical Pharmacology;2024-08-28

2. Real-World Application of a Quantitative Systems Pharmacology (QSP) Model to Predict Potassium Concentrations from Electronic Health Records: A Pilot Case towards Prescribing Monitoring of Spironolactone;Pharmaceuticals;2024-08-07

3. Exploring the discrepancies between clinical trials and real‐world data: A small‐cell lung cancer study;Clinical and Translational Science;2024-08

4. Evolution of Drug Development and Regulatory Affairs: The Demonstrated Power of Artificial Intelligence;Clinical Therapeutics;2024-08

5. A Comprehensive Framework for Evaluating the Value Created by Real-World Evidence for Diverse Stakeholders: The Case for Coordinated Registry Networks;Therapeutic Innovation & Regulatory Science;2024-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3